Basit öğe kaydını göster

dc.contributor.authorOncul, O
dc.contributor.authorKocak, N
dc.contributor.authorAltunay, H
dc.contributor.authorOzsoy, MF
dc.contributor.authorCavuslu, S
dc.date.accessioned2021-03-03T16:01:49Z
dc.date.available2021-03-03T16:01:49Z
dc.date.issued2003
dc.identifier.citationCavuslu S., Oncul O., Altunay H., Ozsoy M., Kocak N., "Seroprevalence of tetanus antibody in Turkish population and effectiveness of single-dose tetanus toxoid", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, cilt.22, sa.7, ss.431-433, 2003
dc.identifier.issn0934-9723
dc.identifier.otherav_4201c638-3e81-4245-8f44-57bad2ba002f
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/48119
dc.identifier.urihttps://doi.org/10.1007/s10096-003-0954-y
dc.description.abstractThe study presented here was performed to determine the rates of immunity to tetanus in a cross section of the Turkish population and to assess the impact of a single-dose tetanus toxoid in previously unvaccinated individuals. Among 18-year-old participants who received their last tetanus booster 4 years prior to the study and 22-year-old participants who received the booster 8 years previously, certain durable protective antibody (>1 IU/ml) was detected in 100%. However, only 3.3% of 20-year-old participants who did not know whether they had been vaccinated as children or young adults had a protective antibody level. After administering a single dose of tetanus vaccine to this group, the rate of protective antibody increased from 3.3% to 96.7%. For the prevention of tetanus, the optimal policy should focus on improving rates of complete primary immunization in adults and children and giving a single booster every 10 years, or at least at age 40 or 50 years.
dc.language.isoeng
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectYaşam Bilimleri
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectİmmünoloji
dc.subjectMikrobiyoloji
dc.subjectTemel Bilimler
dc.titleSeroprevalence of tetanus antibody in Turkish population and effectiveness of single-dose tetanus toxoid
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
dc.contributor.department, ,
dc.identifier.volume22
dc.identifier.issue7
dc.identifier.startpage431
dc.identifier.endpage433
dc.contributor.firstauthorID2209559


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster